| mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.2 |
2e-05 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |